International Journal of Molecular Sciences (Dec 2022)

A Greek National Cross-Sectional Study on Myotonic Dystrophies

  • Georgios K. Papadimas,
  • Constantinos Papadopoulos,
  • Kyriaki Kekou,
  • Chrisoula Kartanou,
  • Athina Kladi,
  • Evangelia Nitsa,
  • Christalena Sofocleous,
  • Evangelia Tsanou,
  • Ioannis Sarmas,
  • Stefania Kaninia,
  • Elisabeth Chroni,
  • Georgios Tsivgoulis,
  • Vasilios Kimiskidis,
  • Marianthi Arnaoutoglou,
  • Leonidas Stefanis,
  • Marios Panas,
  • Georgios Koutsis,
  • Georgia Karadima,
  • Joanne Traeger-Synodinos

DOI
https://doi.org/10.3390/ijms232415507
Journal volume & issue
Vol. 23, no. 24
p. 15507

Abstract

Read online

Myotonic Dystrophies (DM, Dystrophia Myotonia) are autosomal dominant inherited myopathies with a high prevalence across different ethnic regions. Despite some differences, mainly due to the pattern of muscle involvement and the age of onset, both forms, DM1 and DM2, share many clinical and genetic similarities. In this study, we retrospectively analyzed the medical record files of 561 Greek patients, 434 with DM1 and 127 with DM2 diagnosed in two large academic centers between 1994–2020. The mean age at onset of symptoms was 26.2 ± 15.3 years in DM1 versus 44.4 ± 17.0 years in DM2 patients, while the delay of diagnosis was 10 and 7 years for DM1 and DM2 patients, respectively. Muscle weakness was the first symptom in both types, while myotonia was more frequent in DM1 patients. Multisystemic involvement was detected in the great majority of patients, with cataracts being one of the most common extramuscular manifestations, even in the early stages of disease expression. In conclusion, the present work, despite some limitations arising from the retrospective collection of data, is the first record of a large number of Greek patients with myotonic dystrophy and emphasizes the need for specialized neuromuscular centers that can provide genetic counseling and a multidisciplinary approach.

Keywords